BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 10170488)

  • 1. Medical device regulation in the United States and the European Union: a comparative study.
    Chai JY
    Food Drug Law J; 2000; 55(1):57-80. PubMed ID: 12296349
    [No Abstract]   [Full Text] [Related]  

  • 2. Achieving medical device safety in an era of globalization.
    Meritz JK; White TL
    Food Drug Law J; 2008; 63(3):647-55. PubMed ID: 19031664
    [No Abstract]   [Full Text] [Related]  

  • 3. Health economics and technology reimbursement. Payer impact.
    Papatheofanis FJ
    IEEE Eng Med Biol Mag; 2002; 21(1):12. PubMed ID: 11935983
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of FDA reform.
    Trunzo J
    Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring emerging nanobiotechnology drugs and medical devices.
    Paradise J; Diliberto GM; Tisdale AW; Kokkoli E
    Food Drug Law J; 2008; 63(2):407-20. PubMed ID: 18561467
    [No Abstract]   [Full Text] [Related]  

  • 6. Globalization of biotechnology and the public health challenges accompanying it.
    Malinowski MJ
    Albany Law Rev; 1996; 60(1):119-69. PubMed ID: 10170488
    [No Abstract]   [Full Text] [Related]  

  • 7. Production of high-quality marketing applications: strategies for biotechnology companies working with contract research organizations.
    Hecker SJ; Preston C; Foote M
    Biotechnol Annu Rev; 2003; 9():269-77. PubMed ID: 14650931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the US FDA medical device approval process.
    Sastry A
    Curr Cardiol Rep; 2014; 16(6):494. PubMed ID: 24880920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating new refractive surgical procedures: free market madness versus regulatory rigor mortis.
    Waring GO
    J Refract Surg; 1995; 11(5):335-9. PubMed ID: 8528910
    [No Abstract]   [Full Text] [Related]  

  • 10. An overview of drug development in the United States and current challenges.
    Moore SW
    South Med J; 2003 Dec; 96(12):1244-55; quiz 1256. PubMed ID: 14696877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American immunization policies: actions speak louder than words.
    Grabenstein JD
    Hosp Pharm; 1993 Dec; 28(12):1233-4, 1237-40. PubMed ID: 10130619
    [No Abstract]   [Full Text] [Related]  

  • 12. The common technical document: the changing face of the New Drug Application.
    Molzon J
    Nat Rev Drug Discov; 2003 Jan; 2(1):71-4. PubMed ID: 12509761
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.